Female Fertility Rate Statistics in US 2026 | Key Facts

Female Fertility Rate in America 2026

Female fertility in the United States has reached a defining crossroads in 2026. The most recent final data released by the CDC’s National Center for Health Statistics (NCHS) in July 2025 confirmed what many demographers had been watching closely: the US total fertility rate (TFR) fell to 1.599 births per woman in 2024, dipping below the 1.6 threshold for the very first time in American recorded history. That number sits far below the population replacement level of 2.1 births per woman — the benchmark the US last met in 2007 — and puts the country’s birth rate on par with some of the lowest fertility nations in Western Europe. The general fertility rate (GFR) declined to 53.8 births per 1,000 females aged 15–44 in 2024, a 22% drop from the 2007 peak, and the downward trend shows no sign of meaningful reversal. For women, families, and policymakers alike, these numbers carry real weight — not just as demographic abstractions, but as a reflection of how deeply economic pressures, delayed family formation, and shifting cultural norms have reshaped the reproductive landscape of American women.

What makes female fertility rate statistics in the US in 2026 especially layered is the story behind the averages. While overall birth rates are falling, births among women aged 40–44 have continued to rise — a pattern that has held almost every year since 1985 — while birth rates among women under 35 are at or near record lows. The US now has more than 13.4% of women aged 15–49 experiencing impaired fecundity, according to CDC’s National Survey of Family Growth, and the latest NSFG data from 2022–2023 shows 13.7% of women aged 20–49 have used at least one fertility service in their lifetimes. Fertility care has quietly become a mainstream part of American women’s healthcare experience, even as access to that care remains starkly unequal across race and income lines. Understanding the full picture of female fertility in America in 2026 means looking past the headline TFR and into the granular data that shapes individual lives.

Interesting Facts about Female Fertility Rate in the US 2026

Below is a snapshot of the most critical, current, and verified facts on female fertility rates in the United States, sourced exclusively from CDC/NCHS, the National Survey of Family Growth (NSFG), the National ART Surveillance System (NASS), and NIH/NICHD — all official US government sources.

Source: CDC/NCHS Data Brief No. 535 (July 2025); CDC/NCHS Data Brief No. 542 (December 2025); National Vital Statistics Reports Vol. 74, No. 1 (March 2025) and Vol. 74, No. 3 (March 2025); CDC National ART Surveillance System (NASS) 2022 Final Report (December 2024); CDC/NSFG 2015–2019 and 2022–2023; RESOLVE: The National Infertility Association (2024); March of Dimes PeriStats (sourced from CDC/NCHS final natality data)

These facts together tell a story that is both deeply human and urgently demographic. The TFR of 1.599 is not just a number — it reflects a generation of American women navigating economic instability, a high cost of childcare, and a healthcare system where access to fertility treatment is still tightly tied to income and insurance status. The record-low teen birth rate is a genuine public health success, the product of decades of investment in contraceptive access and sex education. But the concurrent fall in birth rates for women in their twenties and early thirties is a different kind of story — one shaped more by choice, circumstance, and financial calculation than by improved access to family planning. And the quiet rise of women aged 40–44 as an increasingly significant share of American births signals a profound shift in how and when American women are building families.

The fertility services data adds another essential dimension. The 13.7% of women aged 20–49 who have used a fertility service — drawn from the brand-new NSFG 2022–2023 cycle published in NCHS Data Brief No. 542 in December 2025 — is a figure that would have seemed remarkable just a generation ago. That nearly 1 in 7 American women of reproductive age has experienced impaired fecundity at some point in her life, and that more than 1 in 10 has sought medical help to get pregnant, means that fertility difficulty is no longer a peripheral experience for American women. It is a mainstream one. The gap between who gets help and who doesn’t — with White non-Hispanic and Asian non-Hispanic women accessing fertility services at significantly higher rates than Black non-Hispanic and Hispanic women — reflects the same racial and income inequalities that run through nearly every dimension of American healthcare.

US Total Fertility Rate Long-Term Trends in the US 2026

Source: CDC/NCHS Data Brief No. 535 (July 2025); National Vital Statistics Reports Vol. 74, No. 1 (March 2025); National Vital Statistics Reports Vol. 74, No. 3 — “Effects of Age-Specific Fertility Trends on Overall Fertility Trends: United States, 1990–2023” (March 2025)

The long arc of America’s total fertility rate tells a clear and consequential story: from near-replacement levels in 2007 to a historic low of 1.599 in 2024, the country has shed roughly 25% of its fertility rate over 17 years. This decline is not a single-cause phenomenon — it reflects shifting patterns in education and workforce participation among women, rising costs of housing and childcare, delayed marriage, and a generation of younger women who are either choosing to have fewer children or finding that circumstances make earlier childbearing impractical. The National Vital Statistics Reports Vol. 74, No. 3, published in March 2025 specifically to examine the age-specific drivers of these trends, found that since 1990, women under 30 shifted from accounting for nearly 70% of all births to well under 50%, while the share contributed by women aged 30 and older expanded dramatically. This structural shift in the age of childbearing is, by itself, mathematically capable of pulling down the TFR even if individual women ultimately have similar lifetime family sizes.

What looks puzzling on the surface — total births rising 1% in 2024 while the GFR fell 1% — is explained entirely by population dynamics. The denominator of women aged 15–44 grew, primarily through immigration and the aging of larger birth cohorts into childbearing age, so more women were present in the population even as the birth rate per woman declined. This is a distinction that matters a great deal for interpreting female fertility rate statistics in the US in 2026. Raw birth counts going up does not mean fertility is recovering — it means the base population of women is bigger. The fertility rate per woman, which is the true measure of reproductive behavior, has been falling consistently and is now at its lowest point in American history. The gap between the 2007 TFR of 2.12 and the 2024 TFR of 1.599 represents a profound generational shift in American family formation that policy changes alone will struggle to reverse quickly.

Female Infertility and Impaired Fecundity Statistics in the US 2026

Source: CDC/NCHS Data Brief No. 542 (December 2025) — “Use of Fertility Services in Women Ages 20–49 in the United States: 2022–2023”; CDC/NCHS National Health Statistics Reports No. 202 (April 2024) — “Infertility and Impaired Fecundity in Women and Men in the United States, 2015–2019”; NIH/NICHD Infertility information page; CDC/NCHS FastStats: Infertility

The 13.4% impaired fecundity rate among women aged 15–49 — drawn from the CDC’s nationally representative NSFG data — is the most reliable and current government estimate of how many American women face some form of difficulty conceiving or carrying a pregnancy to term. What makes this figure particularly important is the clinical definition behind it: impaired fecundity in the NSFG captures both women who struggle to conceive and those who struggle to carry pregnancies successfully, making it a broader and arguably more accurate reflection of the fertility challenge burden than a narrower infertility definition alone. The 26% rate among married childless women — roughly 1 in 4 in this subgroup — underscores how heavily fertility challenges weigh on the couples who are actively trying to start families. These are not abstract statistics; they represent millions of women navigating one of the most emotionally and physically demanding experiences of their lives.

The causes of female infertility in the United States are well-catalogued by NIH/NICHD, with ovulatory dysfunction emerging as the dominant category — particularly in the context of PCOS, which affects an estimated 6–12% of reproductive-age women and is one of the leading drivers of fertility clinic referrals in the country. Endometriosis, affecting an estimated 24–50% of infertile women, is another major contributor that is frequently underdiagnosed due to the lengthy average time between symptom onset and clinical diagnosis. The persistence of these conditions across the US female population, combined with the structural trend toward later childbearing, creates a compounding fertility challenge: women who delay childbearing into their mid-30s are more likely to encounter both age-related fertility decline and conditions like endometriosis that worsen over time without treatment. This is why the data on fertility service use — now running at 10.4% for medical help to get pregnant among women 20–49 — reflects not just a medical trend but a social and demographic reality.

Age-Specific Female Birth Rates in the US 2026

Source: CDC/NCHS Data Brief No. 535 (July 2025) — Martin JA, Hamilton BE, Osterman MJK, “Births in the United States, 2024”; National Vital Statistics Reports Vol. 74, No. 1 (March 2025) — Osterman MJK et al., “Births: Final Data for 2023”; National Vital Statistics Reports Vol. 74, No. 3 (March 2025) — Driscoll AK, Hamilton BE, “Effects of Age-Specific Fertility Trends on Overall Fertility Trends: United States, 1990–2023”

The age-specific birth rate table is the most granular and instructive view of what is actually happening to female fertility in the United States in 2026. The headline takeaway is stark: every age group under 35 either declined or was unchanged in 2024, while only women aged 40–44 posted an increase. The birth rate for teens aged 15–19 fell to a record-low 12.6 per 1,000 — a nearly 79% decline from the 1991 peak of 61.8, representing one of the most dramatic sustained improvements in any public health metric in modern American history. The birth rate for women aged 20–24 also hit a new record low of 55.8, reflecting the reality that the generation of women now in their early twenties is delaying family formation to an extent not seen in prior cohorts. These are women who came of age during the post-2008 economic instability, the pandemic, and a housing market that has made early independent household formation increasingly difficult.

The countertrend at the upper end of the age spectrum is equally striking. Women aged 40–44 are now giving birth at a rate of 12.7 per 1,000, a figure that has risen almost every year since 1985 and reflects the long-running shift toward later childbearing driven by career priorities, educational attainment, relationship formation patterns, and greater access to ART. Women aged 30–34 now represent the highest birth rate of any age group, at 93.7 per 1,000 in 2024 — a position that women in that age bracket did not consistently hold until relatively recently in American demographic history. The NCHS Vol. 74, No. 3 analysis published in March 2025 explicitly documents that the shift of births toward older maternal age groups is a structural driver of the declining TFR: because birth rates among younger women have fallen more sharply than the increases among older women, the net effect on the overall fertility rate is negative. This is the central dynamic shaping female fertility rate statistics in the US heading into 2026.

Fertility Services Use by Race and Income in the US 2026

Source: CDC/NCHS Data Brief No. 542 (December 2025) — Nugent CN, Chandra A, “Use of Fertility Services in Women Ages 20–49 in the United States: 2022–2023”; CDC/NASS 2022 Final Report (December 2024); RESOLVE: The National Infertility Association — State Insurance Mandate Data (2024); USAFacts analysis of CDC/NASS 2022 data

The fertility service utilization data from the brand-new NCHS Data Brief No. 542, published in December 2025 and based on the most recent 2022–2023 NSFG, is the freshest and most authoritative snapshot of who is actually accessing fertility care in America. The racial disparities are stark and consistent: White non-Hispanic women (15.2%) and Asian non-Hispanic women (16.0%) have used any fertility services at roughly twice the rate of Black non-Hispanic (9.5%) and Hispanic women (7.0% for medical help to get pregnant). These gaps are not primarily explained by differences in fertility problem prevalence — the CDC’s own infertility data does not show Black women to have dramatically lower rates of fertility challenges. What the gap reflects is differential access: access shaped by insurance coverage, income, geographic proximity to fertility clinics, and systemic disparities in healthcare engagement and referral patterns that run throughout American medicine. The data is explicit that fertility service use rises directly with family income and is significantly higher among the privately insured compared to those on public insurance or uninsured.

The geographic picture is equally telling. The concentration of ART-conceived births in the Northeast and urban centers — with Washington DC at 7.3%, Massachusetts at 6.2%, and New Jersey at 5.6% — versus the near-absence of ART use in rural Southern and Mountain West states reflects a fertility care infrastructure that is deeply clustered around urban centers with high concentrations of fertility specialists, higher average incomes, and in states that more often have insurance mandates. As of 2024, only 19 states mandate insurance coverage for infertility treatment, leaving the majority of American women in states where a full cycle of IVF — costing $15,000 to $30,000 per cycle — is an out-of-pocket expense that most families simply cannot absorb. This geographic and economic inequality in access to fertility treatment is one of the defining characteristics of female fertility care in the United States in 2026, and it determines, to a significant degree, whose fertility challenges get treated and whose go unaddressed.

ART and IVF Outcomes for Women in the US 2026

Source: CDC/NASS 2022 Final Report and NASS Technical Notes (cdc.gov/art, December 2024); CDC/NASS ART Surveillance page (last reviewed December 2024); USAFacts analysis of CDC/NASS 2022 national summary data (published August 2025); HHS report on IVF costs

The CDC’s National ART Surveillance System provides the most comprehensive government-mandated database of fertility treatment in the world, and the 2022 final figures — the most recently published complete dataset — tell a story of dramatic growth and persistent inequality. The 435,426 ART cycles performed in 2022 represent a 128% increase from 2013, meaning that in under a decade the volume of fertility treatment in the US more than doubled. The 98,289 ART-conceived babies born in 2022 — approximately 1 in every 37 infants — is a number that fundamentally reframes how we think about conception in modern America. IVF is no longer a last resort for a small number of families; it is an increasingly routine part of the reproductive landscape for millions of Americans, and the 184,423 egg and embryo banking cycles in 2022 signal that fertility preservation is growing as rapidly as treatment itself.

The age-stratified success rates are among the most clinically significant figures in all of female fertility statistics in the US in 2026. The drop from 49.7% live-birth rate per retrieval for women under 35 to just 7.7% for women over 40 using their own eggs is one of the starkest age-related gradients in any medical intervention — and it directly shapes the urgency of discussions about fertility preservation and earlier treatment. The finding that 28% of ART patients cited a male infertility factor as a contributing reason for seeking treatment reinforces the conclusion that fertility challenges are a shared, couples-level issue, not a female-only medical concern. The average of 2.5 IVF cycles before achieving a live birth, combined with costs of $15,000 to $30,000 per cycle, means that a successful IVF outcome can cost a family anywhere from $37,000 to $75,000 or more — a financial burden that, absent insurance coverage, effectively restricts access to the most effective fertility intervention available to the upper-income tier of the American population.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE